Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics

Launched by ST. JUDE CHILDREN'S RESEARCH HOSPITAL · Jul 28, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how young adults and adolescents who are survivors of childhood cancer use e-cigarettes, commonly known as vaping, and their interest in quitting. The study aims to explore various factors that may influence their vaping behaviors, including their age, gender, race, and experiences related to their cancer treatment. By gathering this information, the researchers hope to develop and improve a mobile health program designed to help these survivors quit vaping.

To participate in the trial, individuals must be between the ages of 13 and 24, have been treated for cancer, and be currently followed by St. Jude Children's Research Hospital. Participants will be asked about their vaping habits and can expect to engage in discussions that help shape the vaping cessation program. The trial is currently recruiting participants and aims to create a supportive environment for young cancer survivors to address their vaping behaviors.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Study Participants
• • Research participant is 13 to 24 years old at enrollment
• • Research participant is followed by St. Jude Children's Research Hospital (SJCRH)
• • Research participant has a diagnosis of malignancy or a CNS neoplasm
• • Research participant has been identified by the Transition Oncology Program (TOP) as a patient transitioning off active cancer therapy and/or followed by After Completion of Therapy (ACT) Clinic, and/or participating in the St. Jude Lifetime Cohort Study (SJLIFE)
• • Research participant is in remission and at least 3 months from having completed cancer-directed therapy
• • Participant can speak and read English
• • Healthcare Providers
• • Engaged in the healthcare of survivors seen through TOP, ACT, or SJLIFE
• Exclusion Criteria:
• • Study Participants
• • Significant psychiatric or neurologic disorders that would impair compliance with study protocol as indicated by the medical chart